Vi­sion or voodoo? Biotech IPO mas­ter Vivek Ra­maswamy is still set­ting up new biotechs and hatch­ing more deals

In the 18 months since Vivek Ra­maswamy blind­sided the biotech in­dus­try with a record-set­ting IPO for the mys­tery biotech Ax­o­vant, the one-time hedge fund mae­stro …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER